{"SPADE_UN_16219": {"Clinical Information": [], "Patent Information": [], "Sequence Information": {"SPADE ID": "SPADE_UN_16219", "Peptide Name": "Kalata B1 [T16S]", "Source": "Synthetic", "Family": "", "Gene": "Not found", "Sequence": "GLPVCGETCVGGTCNSPGCTCSWPVCTRN", "Sequence Length": 29, "UniProt Entry": ["http://www.uniprot.org/uniprot/P56254"], "Protein Existence": "Not found", "Biological Activity": ["Antimicrobial", "Anticancer"], "Target Organism": "Tumor cells:HeLa  (CC50=43.8±0.5 μM)", "Hemolytic Activity": "Human erythrocytes:Weak active up to 50 µM", "Cytotoxicity": "Not available", "Binding Target": "Not available", "Linear/Cyclic": "Cyclic", "N-terminal Modification": "Free", "C-terminal Modification": "Free", "Stereochemistry": "L", "Structure Description": "Not found", "Formula": "C116H185N35O40S6", "Mass": 2902.31, "PI": 5.96, "Net Charge": 0, "Hydrophobicity": 0.15, "Half Life": "Mammalian:30 hourYeast:>20 hourE.coli:>10 hour", "Literature": [{"Title": "Anticancer and toxic properties of cyclotides are dependent on phosphatidylethanolamine phospholipid targeting", "Pubmed ID": "25099014", "Reference": "Chembiochem. 2014 Sep 5;15(13)1956-65.", "Author": "Troeira Henriques S, Huang YH, Chaousis S, Wang CK, Craik DJ.", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=25099014"}], "Frequent Amino Acids": "CGT", "Absent Amino Acids": "ADFHIKMOQUY", "Basic Residues": 1, "Acidic Residues": 1, "Hydrophobic Residues": 8, "Polar Residues": 18, "Positive Residues": 1, "Negative Residues": 1, "Similar Sequences": [{"SPADE_ID": "SPADE_N_00798", "Similarity": 0.9655172413793104, "Sequence": "GLPVCGETCVGGTCNTPGCTCSWPVCTRN"}, {"SPADE_ID": "SPADE_UN_16218", "Similarity": 0.9655172413793104, "Sequence": "GLPVCGETCVGGTCNYPGCTCSWPVCTRN"}, {"SPADE_ID": "SPADE_UN_16221", "Similarity": 0.9655172413793104, "Sequence": "GLPVCGETCVGGTCNTPGCTCSWWPVCTRN"}]}}}